Previous Close | 2.1500 |
Open | 2.1400 |
Bid | 1.9800 x 3100 |
Ask | 2.0600 x 1200 |
Day's Range | 1.9300 - 2.1521 |
52 Week Range | 1.3900 - 19.2850 |
Volume | |
Avg. Volume | 309,477 |
Market Cap | 75.693M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.6360 |
Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for BOLT
Carriage Services, Pool, The Buckle, Bolt Biotherapeutics and Titan Machinery are part of screen of the week article.
- Ex vivo data support the high frequency of myeloid cells in tumors, even when T cells are not present - REDWOOD CITY, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems, today announced that it will be presenting a poster at the 2022 American Society of Clinical O
Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every...